Mustofa Mustofa

Mustofa Mustofa

Auto-generated profile, based on publicly available information

Mustofa Mustofa

Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Gadjah Mada, Sekip Utara, Yogyakarta 55281

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Heliyon
Verified
Journal Article
Open access
MRMaya Dian Rakhmawatie
Maya Dian Rakhmawatie
TWTri Wibawa
Tri Wibawa
PLPuspita Lisdiyanti
Puspita Lisdiyanti
WPWoro Rukmi Pratiwi
Woro Rukmi Pratiwi
MUMustofa
Mustofa
The main obstacle in antimycobacterial discovery is the extremely slow growth rates of pathogenic mycobacteria that lead to the long incubation times needed in antimycobacterial screening. Some in vitro testings has been developed and are currently available for antimycobacterial screening. The aim of the study was to compare Resazurin Microplate Assay (REMA) and Crystal Violet Decolorization Assay (CVDA) for testing mycobacteria susceptibility to isoniazid and rifampicin as well as for antimycobacterial screening of natural products (NP). Mycobacterium tuberculosis strain H37Rv and Mycobacterium smegmatis strain mc2 155 were used as tested mycobacteria. Serial two-fold dilutions from 0.0625 to 1.0 μg/mL for the isoniazid and rifampicin and from 6.25 to 100.0 μg/mL for the NP A and B were prepared. Tested mycobacteria were then incubated with tested drugs or NPs in each growth medium at 37 °C for 7 days for M. tuberculosis and 3 days for M. smegmatis. MIC values against M. tuberculosis were interpreted 24-48 h after adding resazurin or at least 72 h after adding crystal violet, whereas MIC values against M. smegmatis were interpreted 1 h after adding resazurin or 24 h after adding crystal violet. The MIC values against M. tuberculosis interpreted by REMA were 0.0625, 0.0625, 6.25, and >100 μg/mL for rifampicin, isoniazid, NP A, and NP B, respectively, and those interpreted by CVDA were 0.0625, 0.0625, 6.25, and >100 μg/mL for rifampicin, isoniazid, NP A, and NP B, respectively. Moreover, the MIC values against M. smegmatis interpreted by REMA were 0.0625, >1, 6.25, and 100 μg/mL for rifampicin, isoniazid, NP A, and NP B, respectively, and those interpreted by CVDA were 0.125, >1, 6.25, and >100 μg/mL for rifampicin, isoniazid, NP A, NP B respectively. In conclusion, REMA is faster and easier than CVDA to interpret MIC values, however CVDA produces higher MIC values than REMA for rifampicin and NP B in M. smegmatis susceptibility testing. Therefore, REMA and CVDA can be used for antimycobacterial screening.

16 January 2017 in Bangladesh Journal of Medical Science
Verified
Journal Article
Open access
SDSUFI DESRINI
SUFI DESRINI
-M- Mustofa
- Mustofa
ESEti Nurwening Sholikhah
Eti Nurwening Sholikhah
Background: Doxorubicin chemotherapy may induce the development of resistance in the cancer cells. Overexpression of P-glycoprotein (P-gp) has prominent causative role in this process. Unfortunately, many inhibitory agents do not exert satisfying clinical outcome to overcome resistance. Quercetin, a polyphenolic compound, can be developed as P-gp inhibitor due to its cytotoxic properties.Objective: To investigate the effect of quercetin and doxorubicin combination in inhibiting the development of resistance in MCF-7 cell.Methods: Doxorubicin resistant MCF-7 cell were developed from the parent MCF-7 cell by exposing to 75 nM doxorubicin for 25 days. The inhibitory effect of resistance was evaluated via exposured to 75 nM doxorubicin and 750 nM quercetin combination in the same manner with resistance induction. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) citotoxicity assay and flowcytometry assay were performed to investigate the degree of resistance and to inhibit the development of resistance.Results: The exposure of 75 nM doxorubicin in MCF-7 cells (MCF-7 cells/dox75) exhibited sensitivity significantly decrease and upregulation of P-gp expression. The combination of 750 nM quercetin and 75 nM doxorubicin (MCF-7 cells/ dox75q750) caused a significantly increase in cell sensitivity to doxorubicin (p 0,05).Conclusions: The exposure of 75 nM doxorubicin led to the development of doxorubicin-acquired resistance MCF-7 cell. The combination of quercetin and doxorubicin have potency to inhibit the development of doxorubicin-acquired resistance MCF-7 cell by increasing cell sensitivity and reducing P-gp expression level.Bangladesh Journal of Medical Science Vol.16(1) 2017 p.91-97

1 November 2006
Verified
Journal Article
Closed access
ESEti Nurwening Sholikhah
Eti Nurwening Sholikhah
SUSupargiyono
Supargiyono
JJJumina Jumina
Jumina Jumina
MWMahardika Agus Wijayanti
Mahardika Agus Wijayanti
ITIqmal Tahir
Iqmal Tahir
MUMustofa
Mustofa

1 July 2008
Verified
Journal Article
Closed access
ESE N Sholikhah
E N Sholikhah
MWM A Wijayanti
M A Wijayanti
LNL H Nurani
L H Nurani
MUMustofa
Mustofa

25 August 2017 in Indonesian Journal of Pharmacy
Verified
Journal Article
Open access
PDF file
NNNasrudin Nasrudin
Nasrudin Nasrudin
WWWahyono Wahyono
Wahyono Wahyono
MMMustofa Mustofa
Mustofa Mustofa
RARatna Asmah
Ratna Asmah
Hepatoprotective Activity of Ethyl Acetate Fraction of Senggugu’s Root Bark (Clerodendrum serratum L.Moon) on Rats Induced by CCl4